$SYRE
Spyre Therapeutics, Inc.

2016 Q4 Form 10-Q Financial Statement

#000156459016028480 Filed on November 09, 2016

View on sec.gov

Income Statement

Concept 2016 Q4 2015 Q3
Revenue $1.247M $1.073M
YoY Change -21.32%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.050M $1.360M
YoY Change 26.54% 109.23%
% of Gross Profit
Research & Development $4.740M $3.130M
YoY Change 19.4% 25.7%
% of Gross Profit
Depreciation & Amortization $30.00K $20.00K
YoY Change 0.0% 100.0%
% of Gross Profit
Operating Expenses $6.790M $4.490M
YoY Change 21.68% 42.99%
Operating Profit -$5.543M -$3.417M
YoY Change 38.68%
Interest Expense $70.00K $10.00K
YoY Change 600.0% -109.09%
% of Operating Profit
Other Income/Expense, Net -$10.00K $0.00
YoY Change
Pretax Income -$5.480M -$3.410M
YoY Change 37.34% 4.92%
Income Tax
% Of Pretax Income
Net Earnings -$5.483M -$3.413M
YoY Change 37.52% 5.02%
Net Earnings / Revenue -439.7% -318.08%
Basic Earnings Per Share
Diluted Earnings Per Share -$409.9K -$298.3K
COMMON SHARES
Basic Shares Outstanding 13.43M
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q4 2015 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $63.50M $34.10M
YoY Change 91.84%
Cash & Equivalents $47.75M $30.84M
Short-Term Investments $15.80M $3.300M
Other Short-Term Assets $1.700M $3.400M
YoY Change -51.43%
Inventory
Prepaid Expenses
Receivables $1.200M $4.200M
Other Receivables $0.00 $0.00
Total Short-Term Assets $66.42M $41.70M
YoY Change 73.49%
LONG-TERM ASSETS
Property, Plant & Equipment $599.0K $300.0K
YoY Change 72.13%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $40.00K $0.00
YoY Change 100.0%
Total Long-Term Assets $639.0K $400.0K
YoY Change 73.64%
TOTAL ASSETS
Total Short-Term Assets $66.42M $41.70M
Total Long-Term Assets $639.0K $400.0K
Total Assets $67.06M $42.10M
YoY Change 73.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $168.0K $600.0K
YoY Change -4.55%
Accrued Expenses $3.700M $1.700M
YoY Change 60.87%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.965M $2.400M
YoY Change 57.15%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $132.0K $0.00
YoY Change 388.89%
Total Long-Term Liabilities $132.0K $0.00
YoY Change 388.89%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.965M $2.400M
Total Long-Term Liabilities $132.0K $0.00
Total Liabilities $4.097M $2.500M
YoY Change 60.67%
SHAREHOLDERS EQUITY
Retained Earnings -$45.28M
YoY Change 92.02%
Common Stock $1.000K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $62.97M $39.70M
YoY Change
Total Liabilities & Shareholders Equity $67.06M $42.10M
YoY Change 73.5%

Cashflow Statement

Concept 2016 Q4 2015 Q3
OPERATING ACTIVITIES
Net Income -$5.483M -$3.413M
YoY Change 37.52% 5.02%
Depreciation, Depletion And Amortization $30.00K $20.00K
YoY Change 0.0% 100.0%
Cash From Operating Activities -$4.350M -$3.810M
YoY Change 424.1% 111.67%
INVESTING ACTIVITIES
Capital Expenditures -$120.0K -$140.0K
YoY Change 200.0% 100.0%
Acquisitions
YoY Change
Other Investing Activities $2.680M -$3.330M
YoY Change -670.21%
Cash From Investing Activities $2.560M -$3.460M
YoY Change -601.96% 4842.86%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 -970.0K
YoY Change -100.0% -117.38%
NET CHANGE
Cash From Operating Activities -4.350M -3.810M
Cash From Investing Activities 2.560M -3.460M
Cash From Financing Activities 0.000 -970.0K
Net Change In Cash -1.790M -8.240M
YoY Change 15.48% -322.1%
FREE CASH FLOW
Cash From Operating Activities -$4.350M -$3.810M
Capital Expenditures -$120.0K -$140.0K
Free Cash Flow -$4.230M -$3.670M
YoY Change 435.44% 112.14%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Net Income Loss
NetIncomeLoss
-7308000
CY2016Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
13430833
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
29294000
CY2015Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
3768000
us-gaap Operating Expenses
OperatingExpenses
11818000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
2000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7306000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
4000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4331000
CY2016Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
181000
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
0
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
757336
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
757336
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
10000
us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
228000
CY2015Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3413000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-16215000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7536000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-16211000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
96000
agle Payment For Premium On Investments
PaymentForPremiumOnInvestments
146000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-2000
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-3000
agle Amortization Of Lease Allowance Liability
AmortizationOfLeaseAllowanceLiability
17000
agle Amortization Of Lease Allowance Liability
AmortizationOfLeaseAllowanceLiability
17000
us-gaap Share Based Compensation
ShareBasedCompensation
963000
us-gaap Share Based Compensation
ShareBasedCompensation
348000
us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
51000
us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
1000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-1000
agle Payment For Premium On Investments
PaymentForPremiumOnInvestments
5000
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
80000
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
695000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-126000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4235000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1261000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
528000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
347000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
217000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
181000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
1309000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
618000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-14485000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-10149000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
91000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
168000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
20390000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
3296000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
5766000
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-80000
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
40000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-14635000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-3504000
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
43679000
agle Proceeds From Issuance Of Common Stock Net Of Payments Of Offering Costs
ProceedsFromIssuanceOfCommonStockNetOfPaymentsOfOfferingCosts
49294000
agle Proceeds From Issuance Of Common Stock Net Of Payments Of Offering Costs
ProceedsFromIssuanceOfCommonStockNetOfPaymentsOfOfferingCosts
-1802000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
76000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
49370000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
41877000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
20250000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
28224000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2616000
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30840000
us-gaap Other Significant Noncash Transaction Value Of Consideration Given1
OtherSignificantNoncashTransactionValueOfConsiderationGiven1
349000
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Such management estimates include those related to accruals of research and development related costs, fair values of preferred and common stock, stock-based compensation, and certain company income tax related items. Management bases its estimates on historical experience and on various other market-specific and relevant assumptions that management believes to be reasonable under the circumstances. Actual results could differ significantly from those estimates.</p></div>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">Concentration of Credit Risk</p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">Financial instruments that potentially subject the Company to a concentration of credit risk consist of cash, cash equivalents, and marketable securities. The Company&#8217;s investment policy limits investments to high credit quality securities issued by the U.S. government, U.S. government-sponsored agencies and highly rated banks, subject to certain concentration limits and restrictions on maturities. The Company&#8217;s cash, cash equivalents, and marketable securities are held by financial institutions in the United States that management believes are of high credit quality. Amounts on deposit may at times exceed federally insured limits. The Company has not experienced any losses on its deposits of cash and cash equivalents and its accounts are monitored by management to mitigate risk. The Company is exposed to credit risk in the event of default by the financial institutions holding its cash and cash equivalents and bond issuers.</p></div>
CY2016Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
895000
CY2015Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
571000
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">Reclassification</p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">Certain reclassifications have been made to prior period amounts to conform to current period presentation. These reclassifications did not have an impact on the Company&#8217;s results of operations or financial position as of September 30, 2016 and December 31, 2015.</p></div>
CY2016Q3 agle Accrued Contracted Research And Development Costs
AccruedContractedResearchAndDevelopmentCosts
1699000
CY2015Q4 agle Accrued Contracted Research And Development Costs
AccruedContractedResearchAndDevelopmentCosts
863000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2016Q2 us-gaap Capital Units Authorized
CapitalUnitsAuthorized
510000000
CY2016Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2016Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2016Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2016Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.095
CY2016Q3 agle Working Capital
WorkingCapital
67800000
CY2016Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
68000000
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
0
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
0
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2015Q1 agle Number Of Subsidiary Corporations Owned
NumberOfSubsidiaryCorporationsOwned
7
us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2016Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
45540000
CY2016Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
45540000
CY2016Q3 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
18488000
CY2016Q3 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
4000
CY2016Q3 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1000
CY2016Q3 us-gaap Available For Sale Securities
AvailableForSaleSecurities
18491000
CY2015Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
20238000
CY2015Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
20238000
CY2015Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
3769000
CY2015Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1000
CY2015Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
3768000
CY2016Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
374000
CY2015Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
863000
CY2016Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
165000
CY2015Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
50000
CY2015Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
0
CY2016Q3 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
64031000
CY2015Q4 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
24006000
CY2016Q3 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2016Q3 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
50000
CY2016Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
263000
CY2016Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
284000
CY2016Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
292000
CY2016Q3 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
301000
CY2016Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
1190000
CY2015Q4 us-gaap Security Deposit Liability
SecurityDepositLiability
54000
us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
-18000
CY2016Q3 us-gaap Security Deposit Liability
SecurityDepositLiability
39000
CY2016Q3 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
35000
CY2015Q3 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
35000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
105000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
105000

Files In Submission

Name View Source Status
0001564590-16-028480-index-headers.html Edgar Link pending
0001564590-16-028480-index.html Edgar Link pending
0001564590-16-028480.txt Edgar Link pending
0001564590-16-028480-xbrl.zip Edgar Link pending
agle-10q_20160930.htm Edgar Link pending
agle-20160930.xml Edgar Link completed
agle-20160930.xsd Edgar Link pending
agle-20160930_cal.xml Edgar Link unprocessable
agle-20160930_def.xml Edgar Link unprocessable
agle-20160930_lab.xml Edgar Link unprocessable
agle-20160930_pre.xml Edgar Link unprocessable
agle-ex101_208.htm Edgar Link pending
agle-ex102_535.htm Edgar Link pending
agle-ex311_9.htm Edgar Link pending
agle-ex312_7.htm Edgar Link pending
agle-ex321_8.htm Edgar Link pending
agle-ex322_6.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g20161109053730338342.jpg Edgar Link pending
g20161109053730349343.jpg Edgar Link pending
g20161109053731332344.jpg Edgar Link pending
g20161109053731345345.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending